Cargando…

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic with unprecedented economic and societal impact. Currently, several vaccines are available and multitudes of antiviral treatments have been proposed and tested. Although many of the vaccines show clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonsdottir, Hulda R., Siegrist, Denise, Julien, Thomas, Padey, Blandine, Bouveret, Mendy, Terrier, Olivier, Pizzorno, Andres, Huang, Song, Samby, Kirandeep, Wells, Timothy N.C., Boda, Bernadett, Rosa-Calatrava, Manuel, Engler, Olivier B., Constant, Samuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editions Scientifiques Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057985/ https://www.ncbi.nlm.nih.gov/pubmed/35658229 http://dx.doi.org/10.1016/j.biopha.2022.113058

Ejemplares similares

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2019)

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
por: Checkmahomed, Liva, et al.
Publicado: (2020)

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2020)

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
por: Yip, Ashley Jia Wen, et al.
Publicado: (2022)

Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development
por: Dubois, Julia, et al.
Publicado: (2019)

Avian Cell Line DuckCelt(®)-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac(®)
por: Chupin, Caroline, et al.
Publicado: (2021)

Influenza Viruses and mRNA Splicing: Doing More with Less
por: Dubois, Julia, et al.
Publicado: (2014)

Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood
por: Jonsdottir, Hulda R., et al.
Publicado: (2023)

Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection
por: Pizzorno, Andrés, et al.
Publicado: (2018)

p53 Protein Isoforms: Key Regulators in the Front Line of Pathogen Infections?
por: Terrier, Olivier, et al.
Publicado: (2013)

Author Correction: In vitro virucidal activity of Echinaforce(®), an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
por: Signer, Johanna, et al.
Publicado: (2020)

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
por: Signer, Johanna, et al.
Publicado: (2020)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression
por: Ruffin, Manon, et al.
Publicado: (2021)

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
por: Ashour, Nada A, et al.
Publicado: (2022)

Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model
por: Boda, Bernadett, et al.
Publicado: (2018)

In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in Animals
por: Müller, Joachim, et al.
Publicado: (2020)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Publisher Correction: Molnupiravir: coding for catastrophe
por: Malone, Brandon, et al.
Publicado: (2021)

Molnupiravir, une affaire franco-européenne
por: Manus, Jean-Marie
Publicado: (2021)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Why Molnupiravir Fails in Hospitalized Patients
por: Brown, Ashley N., et al.
Publicado: (2022)

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2
por: Ruffin, M., et al.
Publicado: (2021)

Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults
por: Jonsdottir, Hulda R., et al.
Publicado: (2021)

Coronaviruses and the human airway: a universal system for virus-host interaction studies
por: Jonsdottir, Hulda R., et al.
Publicado: (2016)

Characterization of Human Coronaviruses on Well-Differentiated Human Airway Epithelial Cell Cultures
por: Jonsdottir, Hulda R., et al.
Publicado: (2014)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

Molnupiravir; molecular and functional descriptors of mitochondrial safety
por: Wallace, K.B., et al.
Publicado: (2022)

Efficacy and safety of molnupiravir for COVID-19 patients
por: Fatima, Maurish, et al.
Publicado: (2022)

Concise two-step chemical synthesis of molnupiravir
por: Pereira, Vinícius R. D., et al.
Publicado: (2022)

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
por: Dittmar, Mark, et al.
Publicado: (2021)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
por: Terrier, Olivier, et al.
Publicado: (2021)

Actives from MMV Open Access Boxes? A suggested way forward
por: Samby, Kirandeep, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rt6rqcav7j2vr7ldqu27p4r8mu